Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-14
2010-06-22
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S383000, C514S400000, C548S143000, C548S269400, C548S314700
Reexamination Certificate
active
07741347
ABSTRACT:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
REFERENCES:
patent: 5654451 (1997-08-01), Kari
patent: WO94/15909 (1994-07-01), None
patent: WO2006093867 (2006-09-01), None
patent: WO2006/133326 (2006-12-01), None
patent: WO2007/031791 (2007-03-01), None
patent: WO2007/058384 (2007-05-01), None
patent: WO2007/077186 (2007-07-01), None
patent: WO2007/138242 (2007-12-01), None
patent: WO2008/021927 (2008-02-01), None
patent: WO2008/021936 (2008-02-01), None
patent: WO2008021928 (2008-02-01), None
U.S. Appl. No. 12/030,232, filed Feb. 13, 2008, Bachand, et al.
U.S. Appl. No. 12/029,680, filed Feb. 12, 2008, Bachand, et al.
Bachand Carol
Belema Makonen
Deon Daniel H.
Good Andrew C.
Goodrich Jason
Bristol--Myers Squibb Company
Mingo Pamela A.
Saeed Kamal A
Shterengarts Samantha L
LandOfFree
Hepatitis C virus inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hepatitis C virus inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hepatitis C virus inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4241992